American Diabetes Association - 76th Scientific Sessions (June 10-14, 2016 - New Orleans, Louisiana, USA)

Drugs Today (Barc). 2016 Jun;52(6):361-6. doi: 10.1358/dot.2016.52.6.2516437.

Abstract

The 76th American Diabetes Association (ADA) Scientific Sessions took place in New Orleans, Louisiana, USA. The meeting brought together scientists and professionals from a wide range of disciplines in the field of diabetes and provided a platform for networking, allowing experts and researchers to share ideas and learn about the significant advances in diabetes research, treatment and care. Over the course of the 5 days, participants received exclusive access to more than 2,500 original research presentations.

Keywords: Albiglutide; Dapagliflozin; Diabetes; Empagliflozin; Gla-300; MOD-6031; Saroglitazar; Sitagliptin; Vildagliptin; ZP-4982; ZP-5461.

Publication types

  • Congress

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glucosides / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Phenylpropionates / therapeutic use
  • Pyrroles / therapeutic use

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents
  • Phenylpropionates
  • Pyrroles
  • dapagliflozin
  • saroglitazar
  • empagliflozin